Facial Swelling from Buspar is NOT Common
Facial swelling is not a commonly reported side effect of buspirone (Buspar). According to the FDA drug label, facial edema occurs infrequently (1/100 to 1/1000 patients), and facial swelling specifically appears only in postmarketing reports as a rare occurrence, typically in the context of allergic reactions or angioedema 1.
Common Side Effects to Expect
The most frequently reported adverse effects of buspirone that occur in ≥1% of patients include 1:
- Dizziness (12%) - most common
- Drowsiness (10%)
- Nausea (8%)
- Headache (6%)
- Nervousness (5%)
- Lightheadedness (3%)
These are the side effects patients should anticipate, not facial swelling.
When Facial Swelling Does Occur
If facial swelling develops, consider it a serious allergic reaction requiring immediate evaluation. The FDA label specifically warns about rare allergic reactions including 1:
- Urticaria
- Angioedema
- Facial edema (as part of allergic response)
Recent pharmacovigilance data from the FAERS database (2006-2025) analyzing 1,744 buspirone adverse event reports did not identify facial swelling among the top reported adverse events 2. The most common categories were nervous system and psychiatric disorders, not dermatologic or allergic reactions.
Clinical Context
Large-scale safety data supports the rarity of this reaction:
- In controlled trials with 477 buspirone-treated patients, facial swelling was not reported among adverse events occurring in ≥1% of patients 1
- A review of 984 patients in double-blind studies found no significant facial swelling signals 3
- Long-term safety data from 424 patients treated for 6 months and 264 patients for one year revealed no new or unexpected side effects beyond those seen in short-term use 4
Bottom line: Reassure patients that facial swelling is rare with buspirone. If it occurs, discontinue the medication immediately and evaluate for allergic reaction or angioedema, which requires urgent medical attention.